FDA approves Genentech’s Xolair for food allergies: A new horizon in allergy treatment

Pallavi Madhiraju- February 17, 2024 0

The U.S. Food and Drug Administration (FDA) has approved Xolair (omalizumab) for reducing allergic reactions, including anaphylaxis, that may occur with accidental exposure to foods ... Read More